» Articles » PMID: 39230851

Changes in Skeletal Muscle Mass in the First 3 Months Following Gastrointestinal Cancer Surgery: A Prospective Study

Overview
Journal Ann Surg Oncol
Publisher Springer
Specialty Oncology
Date 2024 Sep 4
PMID 39230851
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Surgical resection is the primary treatment for gastrointestinal (GI) cancers, but postoperative skeletal muscle loss (SML) is common and linked to poor prognosis. This study aims to identify patterns of muscle change, examine its association with quality of life (QoL), and explore predictors of SML in the first 3 months.

Patients And Methods: A prospective cohort study was conducted on patients newly diagnosed with GI cancer and undergoing surgery in China between September 2021 and May 2022. Skeletal muscle mass (SMM) and QoL were assessed at admission, 7 days, 1 month, and 3 months post-surgery. Demographic, clinical data, and biomarkers were collected. Missing data were imputed using multiple imputation. Data were analyzed using growth mixture modelling, bivariate analyses, and logistic regression.

Results: A total of 483 patients completed baseline assessment. Of the 242 patients with complete muscle assessments, 92% experienced SML. Three distinct patterns of muscle change were identified: 57% had normal preoperative SMM with mild postoperative SML, 16% had low preoperative SMM with moderate SML, and 27% had normal preoperative mass but severe postoperative SML. Moderate/severe SML was associated with more postoperative complications, poorer health, and higher symptom burden. Independent predictors included advanced age, preoperative sarcopenia, advanced cancer stage, and low prognostic nutrition index (PNI ≤ 45). The results did not change when using imputed values.

Conclusions: Although SML is prevalent, patterns of muscle change are heterogeneous among patients. Advanced age, preoperative sarcopenia, advanced cancer stage, and cancer-related inflammation are predictors for moderate/severe SML, highlighting the need for early detection and management.

References
1.
Konishi H, Nakada K, Kawamura M, Iwasaki T, Murakami K, Mitsumori N . Impaired Gastrointestinal Function Affects Symptoms and Alimentary Status in Patients After Gastrectomy. World J Surg. 2016; 40(11):2713-2718. DOI: 10.1007/s00268-016-3613-z. View

2.
Osaki T, Matsunaga T, Makinoya M, Shishido Y, Miyatani K, Uchinaka E . Impact of gastrectomy on body composition within 1 month in patients with gastric cancer. Surg Today. 2022; 53(7):834-844. DOI: 10.1007/s00595-022-02633-1. View

3.
Hanna L, Nguo K, Furness K, Porter J, Huggins C . Association between skeletal muscle mass and quality of life in adults with cancer: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2022; 13(2):839-857. PMC: 8977976. DOI: 10.1002/jcsm.12928. View

4.
Ajani J, DAmico T, Bentrem D, Chao J, Cooke D, Corvera C . Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022; 20(2):167-192. DOI: 10.6004/jnccn.2022.0008. View

5.
Gao Q, Hu K, Yan C, Zhao B, Mei F, Chen F . Associated Factors of Sarcopenia in Community-Dwelling Older Adults: A Systematic Review and Meta-Analysis. Nutrients. 2021; 13(12). PMC: 8707132. DOI: 10.3390/nu13124291. View